Journey Medical Corp. (DERM) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$4.97

From 52W high−44.17%

Volume276445.00

Market cap$145.92M

P/E (TTM)—

P/S (TTM)2.1x

Div yield—

Key dataOct 19, 2026

Open

$4.97

From 52W high

−44.17%

Volume

276445.00

Market cap

$145.92M

ValuationView details →

P/E (Fwd)

15.4x

EV/EBITDA

77.9x

P/E (TTM)

—

RSI (14)

31.3

MomentumView details →

1D Return

+4.13%

YTD Return

−33.46%

SummaryUpdated Jun 1, 2026

Journey Medical Corporation (NASDAQ:DERM) is a specialty pharmaceutical company founded in 2014 and headquartered in Scottsdale, Arizona. Originally incorporated as Coronado Dermatology, Inc., the company went public in November 2021 and focuses exclusively on developing and commercializing prescription treatments for dermatological conditions. Journey Medical has built a portfolio of FDA-approved dermatology products targeting conditions such as severe acne, hyperhidrosis (excessive sweating), rosacea, and various topical skin infections, serving the specialized needs of dermatologists and their patients across the United States.

Ask drillr about Journey Medical Corp. →

ValuationView details →

P/E (Fwd)

15.4x

P/E (TTM)

—

EV/EBITDA

77.9x

EV/Sales

2.1x

P/S (TTM)

2.1x

P/B (TTM)

4.5x

ProfitabilityView details →

Gross Margin

62.24%

Net Margin

−8.95%

EBITDA Margin

2.74%

ROE (TTM)

−19.01%

ROA (TTM)

−6.21%

Asset Turnover

0.72x

GrowthView details →

Revenue YoY

+20.89%

EPS YoY

+42.27%

FCF YoY

—

Revenue CAGR 3Y

−5.66%

EPS CAGR 3Y

+34.72%

EBITDA YoY

+257.49%

MomentumView details →

1D Return

+4.13%

YTD Return

−33.46%

1Y Return

−29.05%

RSI (14)

31.3

vs 50D SMA

−24.58%

vs 200D SMA

−24.00%

Capital & dividendView details →

Debt/Equity

0.80x

Current Ratio

1.59x

Quick Ratio

1.41x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.01

EPS Surprise

55.56%

Beats (12Q)

4/12

Next Q EPS Est

$0.02

Avg Surprise (4Q)

15.53%

Rev Surprise

0.82%

Financials snapshotView financials →

Revenue (TTM)

68.18M

Net Income (TTM)

−6.10M

Op. CF (TTM)

−7.49M

Next earningsNov 11, 2026 →

Latest newsMore news →

Starbucks opened its first Starbucks Reserve store in South India, located in Hyderabad, as the sixth Reserve outlet in India.60d ago

Journey Medical Corp reported Q2 2026 revenue of $18.5 million, up 23% year-over-year, with a GAAP net loss of $0.3 million and non-GAAP adjusted EBITDA of $2.862 million.69d ago

Similar companies

Assertio Holdings, Inc.ASRT Organigram Global Inc.OGI Cardiol Therapeutics Inc.CRDL Organogenesis Holdings Inc.ORGO Shenzhen Neptunus Interlong Bio-technique Company Limited08329.HK Extrawell Pharmaceutical Holdings Limited00858.HK Find similar companies →

Latest newsMore news →

Starbucks opened its first Starbucks Reserve store in South India, located in Hyderabad, as the sixth Reserve outlet in India.60d ago Journey Medical Corp reported Q2 2026 revenue of $18.5 million, up 23% year-over-year, with a GAAP net loss of $0.3 million and non-GAAP adjusted EBITDA of $2.862 million.69d ago